Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates

DP Misra, AY Gasparyan, O Zimba - Rheumatology international, 2020 - Springer
Repurposing of antirheumatic drugs has garnered global attention. The aim of this article is
to overview available evidence on the use of widely used antirheumatic drugs …

Open science saves lives: lessons from the COVID-19 pandemic

L Besançon, N Peiffer-Smadja, C Segalas… - BMC Medical Research …, 2021 - Springer
In the last decade Open Science principles have been successfully advocated for and are
being slowly adopted in different research communities. In response to the COVID-19 …

COVID-19 and rheumatoid arthritis

KM D'Silva, ZS Wallace - Current opinion in rheumatology, 2021 - journals.lww.com
Glucocorticoids, but not other DMARDs, are associated with a higher risk of severe COVID-
19 outcomes in RA patients. Further studies are needed to explore the impact of specific …

The surviving sepsis campaign: research priorities for coronavirus disease 2019 in critical illness

CM Coopersmith, M Antonelli, SR Bauer… - Critical care …, 2021 - journals.lww.com
OBJECTIVES: To identify research priorities in the management, pathophysiology, and host
response of coronavirus disease 2019 in critically ill patients. DESIGN: The Surviving Sepsis …

[HTML][HTML] Investigating the prevalence of reactive online searching in the COVID-19 pandemic: infoveillance study

RA Badell-Grau, JP Cuff, BP Kelly… - Journal of medical …, 2020 - jmir.org
Background The ongoing pandemic has placed an unprecedented strain on global society,
health care, governments, and mass media. Public dissemination of government policies …

Let's do better: public representations of COVID-19 science

T Caulfield, T Bubela, J Kimmelman, V Ravitsky - Facets, 2021 - facetsjournal.com
COVID science is being both done and circulated at a furious pace. While it is inspiring to
see the research community responding so vigorously to the pandemic crisis, all this activity …

Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults

F Ader - BMJ open, 2020 - bmjopen.bmj.com
Introduction To find effective and safe treatments for COVID-19, the WHO recommended to
systemically evaluate experimental therapeutics in collaborative randomised clinical trials …

Science's Response to CoVID‐19

MJC Long, Y Aye - ChemMedChem, 2021 - Wiley Online Library
CoVID‐19 is a multi‐symptomatic disease which has made a global impact due to its ability
to spread rapidly, and its relatively high mortality rate. Beyond the heroic efforts to develop …

COVID-19 and disease-modifying anti-rheumatic drugs

KM D'Silva, ZS Wallace - Current rheumatology reports, 2021 - Springer
Abstract Purpose of Review Patients on disease-modifying anti-rheumatic drugs (DMARDs)
remain concerned about potential risks of severe COVID-19 outcomes. Meanwhile, several …

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective

SL Mackie, E Brouwer, R Conway… - The Lancet …, 2021 - thelancet.com
Giant cell arteritis, a common primary systemic vasculitis affecting older people, presents
acutely as a medical emergency and requires rapid specialist assessment and treatment to …